======= KMT2C =======
== Gene Information ==
* **Official Symbol**: KMT2C
* **Official Name**: lysine methyltransferase 2C
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=58508|58508]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q8NEZ4|Q8NEZ4]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=KMT2C&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20KMT2C|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/606833|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: This gene is a member of the myeloid/lymphoid or mixed-lineage leukemia (MLL) family and encodes a nuclear protein with an AT hook DNA-binding domain, a DHHC-type zinc finger, six PHD-type zinc fingers, a SET domain, a post-SET domain and a RING-type zinc finger. This protein is a member of the ASC-2/NCOA6 complex (ASCOM), which possesses histone methylation activity and is involved in transcriptional coactivation. [provided by RefSeq, Jul 2008].
* **UniProt Summary**: Histone methyltransferase. Methylates 'Lys-4' of histone H3. H3 'Lys-4' methylation represents a specific tag for epigenetic transcriptional activation. Central component of the MLL2/3 complex, a coactivator complex of nuclear receptors, involved in transcriptional coactivation. KMT2C/MLL3 may be a catalytic subunit of this complex. May be involved in leukemogenesis and developmental disorder. {ECO:0000269|PubMed:17500065}.
|FYRC|
|FYRN|
|SET|
|PHD|
|MLL3/4 complex|
|histone methyltransferase activity (H3-K4 specific)|
|transferase activity, transferring acyl groups|
|histone H3-K4 methylation|
|histone methyltransferase complex|
|regulation of megakaryocyte differentiation|
|histone lysine methylation|
|peptidyl-lysine methylation|
|histone methylation|
|histone binding|
|protein alkylation|
|protein methylation|
|regulation of myeloid cell differentiation|
|macromolecule methylation|
|transcription coactivator activity|
|methylation|
|peptidyl-lysine modification|
|histone modification|
|covalent chromatin modification|
|regulation of hemopoiesis|
|chromatin organization|
|peptidyl-amino acid modification|
|chromosome organization|
|positive regulation of transcription by RNA polymerase II|
|RNA binding|
|DNA binding|
|positive regulation of transcription, DNA-templated|
|positive regulation of nucleic acid-templated transcription|
|positive regulation of RNA biosynthetic process|
|regulation of immune system process|
|positive regulation of RNA metabolic process|
|regulation of cell differentiation|
|positive regulation of nucleobase-containing compound metabolic process|
|positive regulation of macromolecule biosynthetic process|
|positive regulation of cellular biosynthetic process|
|positive regulation of gene expression|
|positive regulation of biosynthetic process|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp285|GW501516 25μM R06 exp285]]|-1.75|
|[[:results:exp169|BH1 1μM R04 exp169]]|-1.73|
|[[:results:exp468|CB-5083 0.4μM R08 exp468]]|1.78|
|[[:results:exp96|BI-2536 0.02μM R03 exp96]]|1.91|
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 0/726
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/25|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/15|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/14|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/7|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 3638
* **Expression level (log2 read counts)**: 7.24
{{:chemogenomics:nalm6 dist.png?nolink |}}